ACCESS Consortium Exploring Clinical Trials Collaboration & Reliance, Says UK MHRA

The UK’s drug regulator, the MHRA, is exploring new opportunities to work closer with its counterparts from Australia, Canada, Singapore and Switzerland under the ACCESS Consortium group, with a focus on pre-submission scientific advice.